Terms: = Kidney tumors AND RB1, OSRC, ENSG00000139687, 5925, RB, P06400
152 results:
1. Genetic Profiling Uncovers Genome-Wide Loss of Heterozygosity and Provides Insight into Mechanisms of Sarcomatoid Transformation in Chromophobe Renal Cell Carcinoma.
Collins K; Acosta AM; Siegmund SE; Cheng L; Hirsch MS; Idrees MT
Mod Pathol; 2024 Feb; 37(2):100396. PubMed ID: 38043790
[TBL] [Abstract] [Full Text] [Related]
2. NEIL3 promotes cell proliferation of ccRCC via the cyclin D1-Rb-E2F1 feedback loop regulation.
Zhang M; Jiang Y; Wang J; Yue Y; Liu W; Wang L; Li Y; Wang W; Cai H; Yang Z; Ma M; Lu S; Fan J
DNA Repair (Amst); 2024 Jan; 133():103604. PubMed ID: 37992567
[TBL] [Abstract] [Full Text] [Related]
3. Tumor Suppressor Properties of Small C-Terminal Domain Phosphatases in Clear Cell Renal Cell Carcinoma.
Krasnov GS; Puzanov GA; Dashinimaev EB; Vishnyakova KS; Kondratieva TT; Chegodaev YS; Postnov AY; Senchenko VN; Yegorov YE
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629167
[TBL] [Abstract] [Full Text] [Related]
4. Gene mutation profiling and clinical significances in patients with renal cell carcinoma.
Wang Y; He P; Zhou X; Wang C; Fu J; Zhang D; Liao D; Zhou Z; Wu C; Gong W
Clinics (Sao Paulo); 2023; 78():100259. PubMed ID: 37515929
[TBL] [Abstract] [Full Text] [Related]
5. Diosmetin suppresses the progression of ESCC by CDK2/Rb/E2F2/RRM2 pathway and synergies with cisplatin.
Chen Y; Dai X; Chen W; Qiao Y; Bai R; Duan X; Zhang K; Chen X; Li X; Mo S; Cao W; Li X; Liu K; Dong Z; Lu J
Oncogene; 2023 Jul; 42(29):2278-2293. PubMed ID: 37349644
[TBL] [Abstract] [Full Text] [Related]
6. Integrated Metabolomic and Transcriptomic Analysis of Modified Nucleosides for Biomarker Discovery in Clear Cell Renal Cell Carcinoma.
Mohl DA; Lagies S; Zodel K; Zumkeller M; Peighambari A; Ganner A; Plattner DA; Neumann-Haefelin E; Adlesic M; Frew IJ; Kammerer B
Cells; 2023 Apr; 12(8):. PubMed ID: 37190010
[TBL] [Abstract] [Full Text] [Related]
7. Chromophobe Renal Cell Carcinoma with Sarcomatoid Differentiation: Clinicopathologic Correlation and Molecular Findings.
Gama A; Xu H; Yang XJ; Choy B
Int J Surg Pathol; 2024 Feb; 32(1):11-16. PubMed ID: 37063043
[No Abstract] [Full Text] [Related]
8. FAK-mediated phosphorylation at Y464 regulates p85β nuclear translocation to promote tumorigenesis of ccRCC by repressing rb1 expression.
Zhang Y; He B; Zhang D; Zhang Y; Chen C; Zhang W; Yang S; Yao M; Cui G; Gu J; Wang T; Lin Z; Fan Y; Xiong Z; Hao Y
Cell Rep; 2023 Mar; 42(3):112188. PubMed ID: 36857183
[TBL] [Abstract] [Full Text] [Related]
9. SETDB1 Modulates Degradation of Phosphorylated RB and Anticancer Efficacy of CDK4/6 Inhibitors.
Huang Z; Li X; Tang B; Li H; Zhang J; Sun R; Ma J; Pan Y; Yan B; Zhou Y; Ding D; Yan Y; Jimenez R; Orme JJ; Jin X; Yang J; Huang H; Jia Z
Cancer Res; 2023 Mar; 83(6):875-889. PubMed ID: 36637424
[TBL] [Abstract] [Full Text] [Related]
10. A machine learning framework develops a DNA replication stress model for predicting clinical outcomes and therapeutic vulnerability in primary prostate cancer.
Huang RH; Hong YK; Du H; Ke WQ; Lin BB; Li YL
J Transl Med; 2023 Jan; 21(1):20. PubMed ID: 36635710
[TBL] [Abstract] [Full Text] [Related]
11. Cuproptosis-Related MiR-21-5p/FDX1 Axis in Clear Cell Renal Cell Carcinoma and Its Potential Impact on Tumor Microenvironment.
Xie M; Cheng B; Yu S; He Y; Cao Y; Zhou T; Han K; Dai R; Wang R
Cells; 2022 Dec; 12(1):. PubMed ID: 36611966
[TBL] [Abstract] [Full Text] [Related]
12. Molecular and Immunophenotypic Correlates of Metastatic Epithelioid Angiomyolipoma Include Alterations of TP53, rb1, and ATRX.
McCarthy MR; Nichols PE; Sharma V; Stanton ML; Reynolds JP; Pitel BA; Halling KC; Lohse CM; Herrera-Hernandez L; Thompson RH; Leibovich BC; Jimenez RE; Boorjian SA; Cheville JC; Gupta S
Arch Pathol Lab Med; 2023 Jul; 147(7):817-825. PubMed ID: 36308711
[TBL] [Abstract] [Full Text] [Related]
13. Differential expression profiling of onco and tumor-suppressor genes from major-signaling pathways in Wilms' tumor.
Sahu DK; Singh N; Das M; Rawat J; Gupta DK
Pediatr Surg Int; 2022 Nov; 38(11):1601-1617. PubMed ID: 36107237
[TBL] [Abstract] [Full Text] [Related]
14. [Expression and significance of fibroblast growth factor receptor 2 in clear cell renal cell carcinoma].
Cai TY; Zhu ZP; Xu CR; Ji X; Lv TD; Guo ZK; Lin J
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):628-635. PubMed ID: 35950384
[TBL] [Abstract] [Full Text] [Related]
15. Implementing the WHO Global Initiative for Childhood Cancer in Morocco: Survival study for the six indexed childhood cancers.
Mechita NB; Cherkaoui S; Abousselham L; Benmiloud S; Kili A; Kababri ME; Maani K; Houdzi JE; Benajiba N; Madani A; Bennani M; Belakhel L; Bouffet E; Patte C; Harif M; Youbi M; Hessissen L
Pediatr Blood Cancer; 2022 Oct; 69(10):e29788. PubMed ID: 35796382
[TBL] [Abstract] [Full Text] [Related]
16. Synthetic lethality of cyclin-dependent kinase inhibitor Dinaciclib with
Nelson LJ; Castro KE; Xu B; Li J; Dinh NB; Thompson JM; Woytash J; Kipp KR; Razorenova OV
Cell Cycle; 2022 May; 21(10):1103-1119. PubMed ID: 35240916
[TBL] [Abstract] [Full Text] [Related]
17. The genomic landscape of metastatic clear cell renal cell carcinoma after systemic therapy.
van der Mijn JC; Eng KW; Chandra P; Fernandez E; Ramazanoglu S; Sigaras A; Oromendia C; Gudas LJ; Tagawa ST; Nanus DM; Faltas BF; Beltran H; Sternberg CN; Elemento O; Sboner A; Mosquera JM; Molina AM
Mol Oncol; 2022 Jun; 16(12):2384-2395. PubMed ID: 35231161
[TBL] [Abstract] [Full Text] [Related]
18. Brusatol inhibits the growth of renal cell carcinoma by regulating the PTEN/PI3K/AKT pathway.
Wang T; Chen Z; Chen H; Yu X; Wang L; Liu X
J Ethnopharmacol; 2022 Apr; 288():115020. PubMed ID: 35066068
[TBL] [Abstract] [Full Text] [Related]
19. A genomic mutation spectrum of collecting duct carcinoma in the Chinese population.
Zhang H; Lu X; Huang G; Hua M; Zhang W; Wang T; Huang L; Wang Z; Chen Q; Li J; Yang Q; Yang G
BMC Med Genomics; 2022 Jan; 15(1):1. PubMed ID: 34980126
[TBL] [Abstract] [Full Text] [Related]
20. Differences in genomic profile of high-grade urothelial carcinoma according to tumor location.
Park CK; Cho NH
Urol Oncol; 2022 Mar; 40(3):109.e1-109.e9. PubMed ID: 34663543
[TBL] [Abstract] [Full Text] [Related]
[Next]
